id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0915-0002,FDA,FDA-2011-N-0915,Agency Information Collection Activities; Submissions for Office Management and Budget Review; Comment Request; Guidance for Industry on Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application,Notice,General Notice,2012-05-24T04:00:00Z,2012,5,,,2012-05-24T15:47:25Z,2012-12589,0,0,090000648101b320